InflaRx N.V. Common Stock
IFRX Real Time Price USDRecent trades of IFRX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by IFRX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Fused piperidinyl bicyclic and related compounds as modulators of c5a receptor Jun. 04, 2024
-
Patent Title: Treatment of inflammatory diseases with inhibitors of c5a activity Feb. 06, 2024
-
Patent Title: Treatment of inflammatory diseases with inhibitors of c5a activity Oct. 11, 2022
-
Patent Title: Treatment of inflammatory diseases with inhibitors of c5a activity Mar. 15, 2022
-
Patent Title: Fused piperidinyl bicyclic and related compounds as modulators of c5a receptor Oct. 19, 2021
-
Patent Title: Inhibitors of c5a for the treatment of viral pneumonia Dec. 08, 2020
-
Patent Title: Anti-c5a binding moieties with high blocking activity Sep. 15, 2020
-
Patent Title: Treatment of inflammatory diseases with inhibitors of c5a activity Aug. 13, 2019
-
Patent Title: Inhibitors of c5a for the treatment of viral pneumonia Mar. 12, 2019
-
Patent Title: Anti-c5a binding moieties with high blocking activity Oct. 04, 2016
-
Patent Title: Anti-c5a binding moieties with high blocking activity Jul. 07, 2015
-
Patent Title: Anti-c5a binding antibodies with high block activity Aug. 12, 2014
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of IFRX in WallStreetBets Daily Discussion
Recent insights relating to IFRX
Recent picks made for IFRX stock on CNBC
ETFs with the largest estimated holdings in IFRX
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IFRX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.